Overview

Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate whether or not oral viscous budesonide is effective in treating children with Eosinophilic Esophagitis.
Phase:
Phase 2
Details
Lead Sponsor:
Ranjan Dohil
University of California, San Diego
Collaborator:
Meritage Pharma, Inc.
Treatments:
Budesonide
Dexlansoprazole
Lansoprazole